Kardia 12L
房颤患病率被大大低估
40%
心房颤动的患者无症状
20%
心房颤动的患者首次临床表现是中风²
$8.7k
每位房颤患者的医疗费用每年可增加8700美元³
KardiaMobile®
经证明可检测未确诊的房颤并降低总护理成本⁴
#1 受患者青睐的个人心电图品牌，满意度高
易于长期监测，无需使用不舒适的贴片或电线
经FDA核准，即时心律判定让患者安心
远程心脏病监测，可覆盖全国，可当日预约
KardiaMobile® 侦测到的房颤数量多于常规护理
REHEARSE-AF 研究发现，KardiaMobile 组的房颤检测率相比仅使用常规护理增加了将近 4 倍。
- 使用 KardiaMobile 进行房颤筛查的随机对照试验 (n=1001)
- 年龄≥65岁且CHADS-VASc评分≥2的患者
- 12 个月内每周采集 2 次心电图（或如有症状）
运作方式
参考
- Boriani, et al. “Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry.” Am J Med vol. 128,5 (2015): 509-518.2.
- Tayal, A Het al. “Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke.” Neurology vol. 71,21 (2008): 1696-701.
- Calkins, Het al. “HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.” Heart Rhythm vol. 14, 10 (2017): e275-444.
- Halcox, J P Jet al. “Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.” Circulation vol. 136,19 (2017): 1784-1794.